541299 — Dr Lalchandani Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Dr Lalchandani Labs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Preliminary
Revenue
Total Revenue	50.4	48.1	44.5	41.9
Cost of Revenue
Gross Profit	38.3	27.5	35	25
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	56.2	40.1	39.7	40.7
Operating Profit	-5.8	7.96	4.81	1.13
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-15.6	6.17	4.02	0.977
Provision for Income Taxes
Net Income After Taxes	-15.6	6.17	4.17	0.635
Net Income Before Extraordinary Items
Net Income	-15.6	6.17	4.17	0.635
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-15.6	6.17	4.17	0.635
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-2.67	-1.29	0.577	-0.368